Is there any chance It’ll be voted on before the change in government. While the Democrats have a senate majority?It has yet to be brought to the floor for a vote.
Is there any chance It’ll be voted on before the change in government. While the Democrats have a senate majority?
Almost none. As in maybe 0.001%.Is there any chance It’ll be voted on before the change in government. While the Democrats have a senate majority?
I think there’s a loophole for budget bills (which this would probably be part of) where a 51 vote majority is needed instead.Senate majority means nothing, in the US senate legislation has to pass a 60% threshold and there's basically zero chance it does.
There is near zero chances the democrats take back the senate before 2028. The 2026 map doesn’t allow the 4 flips needed without a crazy D+10ish environment. Though it’s very likely they will take the house back.The only viable chance is a complete turnaround in 2 years, if Democrats regain a majority in both chambers, and somehow muscle through a provision in an omnibus budget like what happened with RECOVER. Which did happen in a Republican trifecta so it's not entirely impossible. Just about close to lottery odds.
Koroshetz (on RECOVER) :"Let me just start off by saying that as one of the co-leads in that program, I went into it you know four or five years ago, with the idea that what we're going to be dealing with is ME/CFS. And that it's going to be a hard problem, and that we need to get pristine data..
"The truth of the matter is you know these years later nobody has a cure for Long COVID, there are now some clues - it's very similar to what we see in ME/CFS - so if you look at Dr. Nath's work in the Intramural Studies in people with ME/CFS, he did studies in people with Long COVID and he sees a big overlap and what we're seeing most people are seeing is evidence of chronic inflammation which is not unexpected that's we had thought about in ME/CFS - we have people have published papers where they see certain patterns, and that's also happened in ME/CFS - the stage we're at now is where we have to validate those patterns to see if they stick - many of them were done in small groups of people but now with RECOVER we have samples from thousands and thousands of people so we can have really powerful validation studies. We can bring in AI to look at this data and develop the results of the biosamples, the MRI imaging - you know what have you in RECOVER.
I would say, the thing about RECOVER is that most of the studies are showing that there's persistent virus somewhere in the body and it's not totally clear....Ian Lipkin spent a lot of time trying to understand if there's a persistent virus in people with ME/CFS and he was not able to find it but this is not easy you know this is not easy to find we may have to go back and look again to see which virus this this could be if there persistent virus again in ME/CFS but most of the studies are showing that persistent virus occur"
"Then the issue of if you have chronic inflammation, if you have chronic virus, why do you have fatigue and PEM? That's a you know that's a problem for Long COVID, it's a problem for ME/CFS. So the hope is that we get some answers to these kind of mechanistic questions from the RECOVER people that we can then apply to people with ME/CFS"
"This is not a rare event now in the general theme of infection leading to these kind of symptoms that persist- that affect your immune system and persist for years so we know what happens - now we got to figure out..."
"We have 400 different diseases in our portfolio, that the future really is based on the creativity that's coming in but we don't pay, we don't in general, unless Congress tells us, we don't we don't favor one disease over the other - we're trying to solve all these. None of them are good. We're trying to solve all these diseases we really rely on this creativity coming up and the problem in ME/CFS has been the same problem with people getting care for it - that the the medical community has not really gotten behind the effort to understand and treat people with ME/CFS. The research community has not got behind ME/CFS to put in the creative ideas like you need and we have some really good people but we don't, I don't know how many, but it's not a lot of people who put their career into ME/CFS."
"We need that to happen in ME/CFS and that I think been the big problem - we can't fund if people don't apply - we don't hardly get any applications in ME/CFS research - so we need the applications - the applications come when people get passionate about doing something about a disease and that's something the government, no matter how much money we put out, is not going to do it - it's like people want to do what they really feel passionate about.."
"The good news for ME/CFS is Long COVID completely changed the ball game so people can't say well there's no such thing as chronic post-infectious condition - they did that for years to patients - but they can't do that anymore - and so there you're right out in front and not only that but now you have primary care physicians who are seeing you know lots of Long COVID cases which there's lots of them and they look just like ME/CFS, so I think they're going to get better at that and then the big question for us, for you and I, is can we convert these Long COVID researchers to ME/CFS researchers but I think we have a golden opportunity to do that now we can't squander that - well there's a lot of activity in Long COVID -and at NINDS, we put out calls for grants to study Long COVID and the neurologic effects of Long COVID and you know those people are the people we hope are going to be studying the the ME/CFS cases and in our grants we encourage kind of mixing and looking at ME/CFS and Long COVID together because they're basically chronic infection associated conditions so we have an opportunity now to change things, we we got to make this work that we've got to convert the Long COVID research effort which is you know lots of money, hundreds and hundreds of people you know 15,000 people volunteered for these studies uh so it's an opportunity to make a difference."
Wallitt is one of the more “alternative health friendly” people out there. I could see the opposite happening, him getting a promotion.Maybe RFK will jettison Koroshetz & Walitt…